Rikard Holmdahl
Associate Director
Medical Science
Oxypharma
Sweden
Biography
Professor and Head of Medical Inflammation Research, Lund University. Co-founder of Arexis AB and scientific advisory board member of several biotech companies. Involvement with OxyPharma: Conducts research into the mechanism of action of OxyPharma's RA and MS compounds.
Research Interest
His research interests lie in Healthcare and Medical Sciences. He is the Editor-in-Chief Member of many peer reviewed journals and his area of expertise credits him with many publications in national and international journals. He is committed to highest standards of excellence and it proves through his authorship of many books.
